Page 76 - 22-0424
P. 76

The International Journal of the Royal Society of Thailand
              Volume XI - 2019



              Cheng Y, Wang F, Zhang P, Hu J. Risk prediction with electronic health records:
                      A  deep  learning  approach.  SDM.  2016;432–440.  doi:10.1137/1.9781
                      611974348.49.

              Chmielewski M, Lindholm B, Stenvinkel P, Ekstrom JT. The role of epigenetics in
                      kidney diseases. Prilozi. 2011;32:45–54.

              Curtis LM and Agarwal A. Heme oxygenase-1 gene polymorphisms-toward
                      precision medicine for AKI. J Am Soc Nephrol. 2016;27:3229–3231.
                      doi:10.1681/ASN.2016060699.

              D'Oto A, Tian Q-W, Davidoff AM, Yang J. Histone demethylases and their roles
                      in cancer epigenetics. J Med Oncol Ther. 2016;1:34–40.

              Devarajan P. Genomic and proteomic characterization of acute kidney injury.
                      Nephron. 2015;131:85–91. doi:10.1159/000437237.

              Doyle JF and Forni LG. Acute kidney injury: short-term and long-term effects.
                      Crit Care. 2016;20:188. doi:10.1186/s13054-016-1353-y.

              Ebert MS and Sharp PA. Roles for microRNAs in conferring robustness to
                      biological processes. Cell. 2012;149:515–524. doi:10.1016/j.cell.2012.04.005.
              Fieghen HE, Friedrich JO, Burns KE, Nisenbaum R, Adhikari NK, Hladunewich
                      MA, et al. The hemodynamic tolerability and feasibility of sustained low
                      efficiency dialysis in the management of critically ill patients with acute

                      kidney injury. BMC Nephrol. 2010;11:32–32. doi:10.1186/1471-2369-11-32.
              Fontecha-Barriuso M, Martin-Sanchez D, Ruiz-Andres O, Poveda J, Sanchez-Niño
                      MD, Valiño-Rivas L, et al. Targeting epigenetic DNA and histone

                      modifications to treat kidney disease. Nephrol Dial Transplant.
                      2018;33:1875–1886. doi:10.1093/ndt/gfy009.
              Gaudry S, Hajage D, Schortgen F, Martin-Lefevre L, Pons B, Boulet E, et al.
                      Initiation strategies for renal-replacement therapy in the intensive care
                      unit. N Engl J Med. 2016;375:122–133. doi:10.1056/NEJMoa1603017.

              Ginsburg GS and Phillips KA. Precision medicine: from science to value. Health
                      Aff (Millwood). 2018;37:694–701. doi: 10.1377/hlthaff.2017.1624.

              Gunnerson KJ, Shaw AD, Chawla LS, Bihorac A, Al-Khafaji A, Kashani K, et al.
                      TIMP2*IGFBP7 biomarker panel accurately predicts acute kidney injury in






              70                                                Precision Medicine in Acute kidney injury




                                                                                                  11/7/2565 BE   13:28
       _22-0424(055-076)7.indd   70                                                               11/7/2565 BE   13:28
       _22-0424(055-076)7.indd   70
   71   72   73   74   75   76   77   78   79   80   81